Nextgen Biomed Ltd
Symbol: NXGN.TA
TLV
101.8
ILATržní cena dnes
-106.3909
Poměr P/E
0.0000
Poměr PEG
7.56M
MRK Cap
- 0.00%
Výnos DIV
Nextgen Biomed Ltd (NXGN-TA) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 5.2 | 12 | 5.7 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 5.3 | 12.3 | 5.9 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1.6 | 7.3 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.1 | 4.1 | 2.4 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 9.6 | 11.4 | 2.4 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 14.9 | 23.6 | 8.3 | |||||||||
balance-sheet.row.account-payables | 0 | 0.2 | 0.1 | 0.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.1 | 0.6 | 1.4 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1.4 | 2.1 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 2.6 | 2.9 | 1.5 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.retained-earnings | 0 | -51.9 | -43.3 | -40.7 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 64.2 | 64.1 | 47.7 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12.4 | 20.8 | 7 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 14.9 | 23.6 | 8.3 | |||||||||
balance-sheet.row.minority-interest | 0 | -0.1 | -0.1 | -0.1 | |||||||||
balance-sheet.row.total-equity | 0 | 12.3 | 20.7 | 6.9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-debt | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | -5.2 | -12 | -5.7 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -8.6 | -2.5 | -1.3 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 5 | -0.1 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.2 | 0.2 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0.7 | 0 | -0.2 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | 0 | -0.1 | 0 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.5 | 0 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -0.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -2 | -1.9 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4 | -2.5 | -2.4 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 11.4 | 7 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0 | 0.7 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 11.4 | 7.7 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | -6.7 | 6.3 | 3.8 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 5.2 | 11.9 | 5.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12 | 5.7 | 1.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | -2.8 | -2.7 | -1.5 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.5 | 0 | ||||||||||
cash-flows.row.free-cash-flow | 0 | -2.8 | -3.2 | -1.5 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | -5 | 0 | 0 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 3.6 | 2.8 | 1.3 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3.6 | 2.8 | 1.3 | ||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.3 | 0 | ||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.7 | 0.3 | 0 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | -5 | 0 | 0 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.7 | 0.3 | 0 | ||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | -9.3 | -2.8 | -1.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | -8.6 | -2.6 | -1.3 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 0.8 | 0.3 | 0 | ||||||||||
income-statement-row.row.net-income | 0 | -8.6 | -2.5 | -1.3 |
Často kladené otázky
Co je Nextgen Biomed Ltd (NXGN.TA) celková aktiva?
Nextgen Biomed Ltd (NXGN.TA) celková aktiva jsou 14888000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.000.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.200.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.000.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.000.
Co je Nextgen Biomed Ltd (NXGN.TA) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -8572000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 0.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 3581000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.